[Code of Federal Regulations]
[Title 16, Volume 2]
[Revised as of January 1, 2007]
From the U.S. Government Printing Office via GPO Access
[CITE: 16CFR1028.113]

[Page 113-114]
 
                     TITLE 16--COMMERCIAL PRACTICES
 
             CHAPTER II--CONSUMER PRODUCT SAFETY COMMISSION
 
PART 1028_PROTECTION OF HUMAN SUBJECTS--Table of Contents
 
Sec.  1028.113  Suspension or termination of IRB approval of research.

    An IRB shall have authority to suspend or terminate approval of 
research that is not being conducted in accordance with the IRB's 
requirements or

[[Page 114]]

that has been associated with unexpected serious harm to subjects. Any 
suspension or termination of approval shall include a statement of the 
reasons for the IRB's action and shall be reported promptly to the 
investigator, appropriate institutional officials, and the department or 
agency head.

(Approved by the Office of Management and Budget under Control Number 
0990-0260)

[56 FR 28012, 28019, June 18, 1991, as amended at 70 FR 36328, June 23, 
2005]